Bain, S., Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., . . . Mustonen, J. (2004). Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy. New England Journal of Medicine, 351(19), pp. 1952-1961. doi:10.1056/NEJMoa042274

Bain, Steve, Anthony H. Barnett, Stephen C. Bain, Paul Bouter, Bengt Karlberg, Sten Madsbad, Jak Jervell, and Jukka Mustonen. "Angiotensin-Receptor Blockade Versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy." New England Journal of Medicine 351, no. 19 (2004): 1952-1961.

Bain, Steve, et al. "Angiotensin-Receptor Blockade Versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy." New England Journal of Medicine 351.19 (2004): 1952-1961.